CBT
GILD icon

Crews Bank & Trust’s Gilead Sciences GILD Stock Holding History

Crews Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.5K Sell
336
-52
-13% -$6.85K 0.01% 397
2026
Q1 		$54.1K Buy
388
+52
+15% +$7.28K 0.01% 352
2025
Q4 		$41.2K Hold
336
– – 0.01% 383
2025
Q3 		$37.3K Hold
336
– – 0.01% 400
2025
Q2 		$37.3K Hold
336
– – 0.01% 390
2025
Q1 		$37.6K Hold
336
– – 0.01% 380
2024
Q4 		$31K Buy
+336
New +$30.3K 0.01% 393

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Crews Bank & Trust's GILD Position: Q2 2026 in Review

Crews Bank & Trust reduced its Gilead Sciences (GILD) stake by 13% in Q2 2026, selling an estimated $6.85K and leaving 336 shares worth $42.5K. The position accounts for 0.01% of the portfolio, ranked #397.

Crews Bank & Trust first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $54.1K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Crews Bank & Trust held 336 shares of Gilead Sciences worth $42.5K as of Q2 2026.
  • Crews Bank & Trust sold 52 Gilead Sciences shares in Q2 2026, an estimated $6.85K.
  • Gilead Sciences made up 0.01% of Crews Bank & Trust's portfolio in Q2 2026, its #397 holding.
  • Crews Bank & Trust first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Crews Bank & Trust's Gilead Sciences position peaked at $54.1K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.